Logo image of 5Q5.DE

SNOWFLAKE INC (5Q5.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:5Q5 - US8334451098 - Common Stock

189.56 EUR
-0.3 (-0.16%)
Last: 12/30/2025, 7:00:00 PM
Fundamental Rating

4

5Q5 gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 68 industry peers in the IT Services industry. The financial health of 5Q5 is average, but there are quite some concerns on its profitability. 5Q5 is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year 5Q5 was profitable.
5Q5 had a positive operating cash flow in the past year.
5Q5 had negative earnings in each of the past 5 years.
5Q5 had a positive operating cash flow in 4 of the past 5 years.
5Q5.DE Yearly Net Income VS EBIT VS OCF VS FCF5Q5.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B

1.2 Ratios

5Q5's Return On Assets of -16.40% is on the low side compared to the rest of the industry. 5Q5 is outperformed by 88.24% of its industry peers.
With a Return On Equity value of -63.27%, 5Q5 is not doing good in the industry: 86.76% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -16.4%
ROE -63.27%
ROIC N/A
ROA(3y)-11.57%
ROA(5y)-10.81%
ROE(3y)-24.53%
ROE(5y)-19.6%
ROIC(3y)N/A
ROIC(5y)N/A
5Q5.DE Yearly ROA, ROE, ROIC5Q5.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

The Gross Margin of 5Q5 (67.07%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of 5Q5 has grown nicely.
5Q5 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 67.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.14%
GM growth 5Y3.51%
5Q5.DE Yearly Profit, Operating, Gross Margins5Q5.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

5

2. Health

2.1 Basic Checks

5Q5 does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 5Q5 remains at a similar level compared to 1 year ago.
5Q5 has more shares outstanding than it did 5 years ago.
5Q5 has a worse debt/assets ratio than last year.
5Q5.DE Yearly Shares Outstanding5Q5.DE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
5Q5.DE Yearly Total Debt VS Total Assets5Q5.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

5Q5 has an Altman-Z score of 6.05. This indicates that 5Q5 is financially healthy and has little risk of bankruptcy at the moment.
5Q5 has a better Altman-Z score (6.05) than 95.59% of its industry peers.
The Debt to FCF ratio of 5Q5 is 2.96, which is a good value as it means it would take 5Q5, 2.96 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.96, 5Q5 is in the better half of the industry, outperforming 60.29% of the companies in the same industry.
5Q5 has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.07, 5Q5 is doing worse than 69.12% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 2.96
Altman-Z 6.05
ROIC/WACCN/A
WACC8.93%
5Q5.DE Yearly LT Debt VS Equity VS FCF5Q5.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B 5B

2.3 Liquidity

5Q5 has a Current Ratio of 1.37. This is a normal value and indicates that 5Q5 is financially healthy and should not expect problems in meeting its short term obligations.
5Q5 has a better Current ratio (1.37) than 64.71% of its industry peers.
A Quick Ratio of 1.37 indicates that 5Q5 should not have too much problems paying its short term obligations.
5Q5 has a better Quick ratio (1.37) than 69.12% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.37
5Q5.DE Yearly Current Assets VS Current Liabilites5Q5.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

9

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 42.53% over the past year.
The Earnings Per Share has been growing by 334.45% on average over the past years. This is a very strong growth
5Q5 shows a strong growth in Revenue. In the last year, the Revenue has grown by 28.48%.
The Revenue has been growing by 68.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)42.53%
EPS 3Y334.45%
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)28.48%
Revenue growth 3Y43.81%
Revenue growth 5Y68.78%
Sales Q2Q%28.75%

3.2 Future

5Q5 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.35% yearly.
The Revenue is expected to grow by 23.67% on average over the next years. This is a very strong growth
EPS Next Y50.64%
EPS Next 2Y42.47%
EPS Next 3Y41.09%
EPS Next 5Y39.35%
Revenue Next Year29.42%
Revenue Next 2Y26.73%
Revenue Next 3Y25.39%
Revenue Next 5Y23.67%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
5Q5.DE Yearly Revenue VS Estimates5Q5.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B
5Q5.DE Yearly EPS VS Estimates5Q5.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 4 6 8 10

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 180.53, which means the current valuation is very expensive for 5Q5.
Based on the Price/Earnings ratio, 5Q5 is valued a bit more expensive than the industry average as 75.00% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 26.77. 5Q5 is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 133.89, 5Q5 can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 5Q5 indicates a slightly more expensive valuation: 5Q5 is more expensive than 70.59% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.35. 5Q5 is valued rather expensively when compared to this.
Industry RankSector Rank
PE 180.53
Fwd PE 133.89
5Q5.DE Price Earnings VS Forward Price Earnings5Q5.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, 5Q5 is valued a bit more expensive than 73.53% of the companies in the same industry.
Industry RankSector Rank
P/FCF 98.14
EV/EBITDA N/A
5Q5.DE Per share data5Q5.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as 5Q5's earnings are expected to grow with 41.09% in the coming years.
PEG (NY)3.57
PEG (5Y)N/A
EPS Next 2Y42.47%
EPS Next 3Y41.09%

0

5. Dividend

5.1 Amount

No dividends for 5Q5!.
Industry RankSector Rank
Dividend Yield 0%

SNOWFLAKE INC

FRA:5Q5 (12/30/2025, 7:00:00 PM)

189.56

-0.3 (-0.16%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)12-03 2025-12-03/amc
Earnings (Next)02-24 2026-02-24/amc
Inst Owners74.32%
Inst Owner ChangeN/A
Ins Owners2.41%
Ins Owner ChangeN/A
Market Cap64.22B
Revenue(TTM)4.39B
Net Income(TTM)-1.35B
Analysts81.79
Price Target245.64 (29.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.9%
Min EPS beat(2)10.63%
Max EPS beat(2)29.18%
EPS beat(4)4
Avg EPS beat(4)29.73%
Min EPS beat(4)10.37%
Max EPS beat(4)68.73%
EPS beat(8)7
Avg EPS beat(8)28.63%
EPS beat(12)11
Avg EPS beat(12)66.06%
EPS beat(16)14
Avg EPS beat(16)111.07%
Revenue beat(2)2
Avg Revenue beat(2)1.9%
Min Revenue beat(2)0.66%
Max Revenue beat(2)3.15%
Revenue beat(4)4
Avg Revenue beat(4)1.62%
Min Revenue beat(4)0.66%
Max Revenue beat(4)3.15%
Revenue beat(8)8
Avg Revenue beat(8)1.61%
Revenue beat(12)11
Avg Revenue beat(12)1.2%
Revenue beat(16)15
Avg Revenue beat(16)1.34%
PT rev (1m)3.95%
PT rev (3m)8.24%
EPS NQ rev (1m)-7.96%
EPS NQ rev (3m)-8.48%
EPS NY rev (1m)1.16%
EPS NY rev (3m)1.21%
Revenue NQ rev (1m)1.67%
Revenue NQ rev (3m)1.91%
Revenue NY rev (1m)1.06%
Revenue NY rev (3m)1.09%
Valuation
Industry RankSector Rank
PE 180.53
Fwd PE 133.89
P/S 17.21
P/FCF 98.14
P/OCF 86.44
P/B 35.4
P/tB 107.65
EV/EBITDA N/A
EPS(TTM)1.05
EY0.55%
EPS(NY)1.42
Fwd EY0.75%
FCF(TTM)1.93
FCFY1.02%
OCF(TTM)2.19
OCFY1.16%
SpS11.01
BVpS5.35
TBVpS1.76
PEG (NY)3.57
PEG (5Y)N/A
Graham Number11.25
Profitability
Industry RankSector Rank
ROA -16.4%
ROE -63.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 67.07%
FCFM 17.54%
ROA(3y)-11.57%
ROA(5y)-10.81%
ROE(3y)-24.53%
ROE(5y)-19.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.14%
GM growth 5Y3.51%
F-Score4
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 2.96
Debt/EBITDA N/A
Cap/Depr 49.21%
Cap/Sales 2.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 1.37
Altman-Z 6.05
F-Score4
WACC8.93%
ROIC/WACCN/A
Cap/Depr(3y)67.21%
Cap/Depr(5y)189.07%
Cap/Sales(3y)2.66%
Cap/Sales(5y)4.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.53%
EPS 3Y334.45%
EPS 5YN/A
EPS Q2Q%75%
EPS Next Y50.64%
EPS Next 2Y42.47%
EPS Next 3Y41.09%
EPS Next 5Y39.35%
Revenue 1Y (TTM)28.48%
Revenue growth 3Y43.81%
Revenue growth 5Y68.78%
Sales Q2Q%28.75%
Revenue Next Year29.42%
Revenue Next 2Y26.73%
Revenue Next 3Y25.39%
Revenue Next 5Y23.67%
EBIT growth 1Y-3.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year254.09%
EBIT Next 3Y82.41%
EBIT Next 5Y65.79%
FCF growth 1Y21.94%
FCF growth 3Y149.6%
FCF growth 5YN/A
OCF growth 1Y21.18%
OCF growth 3Y105.76%
OCF growth 5YN/A

SNOWFLAKE INC / 5Q5.DE FAQ

What is the fundamental rating for 5Q5 stock?

ChartMill assigns a fundamental rating of 4 / 10 to 5Q5.DE.


Can you provide the valuation status for SNOWFLAKE INC?

ChartMill assigns a valuation rating of 1 / 10 to SNOWFLAKE INC (5Q5.DE). This can be considered as Overvalued.


How profitable is SNOWFLAKE INC (5Q5.DE) stock?

SNOWFLAKE INC (5Q5.DE) has a profitability rating of 2 / 10.


What are the PE and PB ratios of SNOWFLAKE INC (5Q5.DE) stock?

The Price/Earnings (PE) ratio for SNOWFLAKE INC (5Q5.DE) is 180.53 and the Price/Book (PB) ratio is 35.4.


Can you provide the expected EPS growth for 5Q5 stock?

The Earnings per Share (EPS) of SNOWFLAKE INC (5Q5.DE) is expected to grow by 50.64% in the next year.